Euglycemic Diabetic Ketoacidosis: Diagnosis and Management
Euglycemic DKA (blood glucose ≤250 mg/dL) is diagnosed when metabolic acidosis (pH <7.3 AND bicarbonate <18 mEq/L) and elevated ketones are present, even without hyperglycemia, and requires the same aggressive treatment as classic DKA with the critical addition of dextrose-containing IV fluids from the start. 1
Diagnostic Criteria
All three criteria must be met simultaneously:
- Metabolic acidosis: arterial or venous pH <7.3 AND serum bicarbonate <18 mEq/L 1, 2
- Ketosis: elevated blood β-hydroxybutyrate (preferred) or positive urine/serum ketones 1, 2
- Euglycemia or mild hyperglycemia: plasma glucose <200–250 mg/dL 1, 2
- Either documented hyperglycemia at any point OR known history of diabetes 1, 2
Approximately 10% of all DKA presentations are euglycemic, making this a common enough variant that it should never be missed. 1, 2
Essential Laboratory Workup
Order immediately when euglycemic DKA is suspected:
- Blood β-hydroxybutyrate (gold standard—do NOT rely on urine ketones or nitroprusside tests, which miss β-OHB, the predominant ketone) 2, 3
- Arterial or venous blood gas (venous pH is 0.03 units lower than arterial and is sufficient for monitoring) 2, 3
- Basic metabolic panel with calculated anion gap (should be >10–12 mEq/L) 2, 3
- Serum osmolality 2
- Complete blood count with differential 2, 4
- Urinalysis and urine/blood cultures if infection suspected 3, 4
- Electrocardiogram 2, 4
Critical pitfall: Nitroprusside-based urine or serum ketone tests only detect acetoacetate and acetone, completely missing β-hydroxybutyrate, which is the predominant and strongest ketoacid in DKA. During treatment, β-OHB converts to acetoacetate, making these tests falsely suggest worsening ketosis when the patient is actually improving. 2, 3
Common Precipitating Factors
SGLT2 inhibitors are the most common modern cause of euglycemic DKA. 1, 2, 4 Other key triggers include:
- Pregnancy (up to 2% of pregnancies with pregestational diabetes; can present with mixed acid-base disturbances) 1, 2, 4
- Reduced caloric intake: very-low-carbohydrate/ketogenic diets, prolonged fasting, poor oral intake during illness 1, 2, 4, 5
- Alcohol consumption (heavy or chronic use) 1, 2, 4
- Chronic liver disease 1, 2, 4
- Recent insulin use (lowers glucose while ketoacidosis persists) 2, 4, 6
- Acute illness, infection, or physiologic stress (UTI, MI, surgery, dehydration) 4
Management Protocol
Immediate Resuscitation
1. Aggressive fluid resuscitation:
- Start isotonic saline (0.9% NaCl) at 15–20 mL/kg/hour for the first hour 2, 3, 7
- Total body water deficit is typically 6–9 L; replace over 24 hours 2, 3
- Monitor closely for fluid overload in patients with renal or cardiac compromise 2, 3
2. Potassium management (check BEFORE starting insulin):
- K+ <3.3 mEq/L: DELAY insulin, give aggressive potassium replacement first to prevent fatal arrhythmias 2, 3
- K+ 3.3–5.5 mEq/L: add 20–30 mEq/L potassium to IV fluids (2/3 KCl, 1/3 KPO₄) 2, 3
- K+ >5.5 mEq/L: hold potassium, recheck frequently 2, 3
Insulin and Glucose Management
3. Insulin therapy (once K+ ≥3.3 mEq/L):
- Continuous IV regular insulin at 0.1 units/kg/hour (no initial bolus) 2, 3
- If glucose does not fall by ≥50 mg/dL in first hour, double the rate hourly until steady decline of 50–75 mg/dL/hour 3
4. Critical difference from classic DKA—add dextrose EARLY:
- Add 5–10% dextrose to IV fluids immediately or when glucose falls to 200–250 mg/dL 1, 2, 3, 7
- Continue insulin infusion despite normal glucose levels to clear ketones 1, 2, 7
- Adults require 150–200 grams of carbohydrate daily to suppress ketogenesis; insulin alone cannot clear ketones without adequate glucose substrate 3
Critical pitfall: Do NOT stop insulin when glucose normalizes. Ketoacidosis takes longer to resolve than hyperglycemia, and premature cessation causes recurrence. 2, 3
Monitoring
5. Laboratory monitoring every 2–4 hours:
- Glucose, electrolytes (Na+, K+, Cl-), BUN, creatinine 2, 3
- Venous pH and anion gap (arterial blood gases not needed after initial diagnosis) 2, 3
- Blood β-hydroxybutyrate (not urine ketones) 2, 3
Resolution Criteria
DKA is resolved only when ALL of the following are met:
Transition to Subcutaneous Insulin
6. Before stopping IV insulin:
- Administer basal subcutaneous insulin (NPH, detemir, glargine, or degludec) 2–4 hours before discontinuing IV infusion to prevent rebound hyperglycemia 2, 3
- Estimate basal dose by averaging IV insulin rate over preceding 12 hours 3
Special Populations
Type 1 Diabetes
- Never stop or hold basal insulin, even if not eating 1
- Provide detailed sick-day instructions on insulin dose adjustments during illness or fasting 1
Pregnancy
- Pregnant individuals may present with euglycemic DKA and mixed acid-base disturbances 1, 2
- Due to significant risk of feto-maternal harm, counsel on signs/symptoms and instruct to seek immediate medical attention if DKA is suspected 1
SGLT2 Inhibitor Users
- Stop SGLT2 inhibitor immediately and do not restart until metabolically stable for 3–4 days 3, 4
- Discontinue at least 3 days before elective surgery or procedures requiring fasting 4
- Educate patients to stop medication and seek immediate care for nausea, vomiting, abdominal pain, or weakness 4
Differential Diagnosis
Rule out other causes of high anion gap metabolic acidosis:
- Alcoholic ketoacidosis: glucose typically normal to mildly elevated (rarely >250 mg/dL) or hypoglycemic, history of alcohol use 1, 2
- Starvation ketosis: serum bicarbonate typically ≥18 mEq/L, less severe acidosis, prolonged fasting history 1, 2
- Lactic acidosis 2
- Toxic ingestions (salicylates, methanol, ethylene glycol) 2
Key Pitfalls to Avoid
- Do NOT rely on urine ketones or nitroprusside tests for diagnosis or monitoring 2, 3
- Do NOT stop insulin when glucose normalizes—ketoacidosis resolves more slowly 2, 3
- Do NOT withhold dextrose-containing fluids in euglycemic DKA—both insulin and glucose are required to clear ketones 3, 7
- Do NOT use bicarbonate therapy unless pH <6.9 (no benefit demonstrated) 2, 3
- Do NOT use subcutaneous insulin in critically ill or unconscious patients 3